| Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability (NCT04945278) | University Hospital, Brest | 2022-05-31 |
| The Effect of D-serine as add-on Therapy in Recent-onset Psychosis (NCT04140773) | Dragos Inta | 2021-11-25 |
| A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis (NCT04968275) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-08-23 |
| Treating Early Stages With an Intervention Targeting Cognitive Reserve (NCT05288049) | Hospital Clinic of Barcelona | 2021-01-01 |
| Mobile After-Care Support App: Pilot RCT (NCT03955250) | Butler Hospital | 2019-05-31 |
| Mindfulness-Based Family Psychoeducation Intervention for Early Psychosis (NCT03688009) | The Hong Kong Polytechnic University | 2019-01-01 |
| Peer Support for Exercise in Older Veterans With Psychotic Disorders (NCT02958007) | VA Office of Research and Development | 2018-06-01 |
| Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders (NCT03671005) | Charite University, Berlin, Germany | 2018-05-01 |
| Gut Microbiome in AP Naive (NCT03414151) | Centre for Addiction and Mental Health | 2018-02-07 |
| Thinking Skills at Work: Cognitive Remediation Therapy for Patients With Serious Mental Illness (NCT03483701) | Fraser Health | 2017-04-01 |
| Well Being And Resilience: Mechanisms of Transmission of Health and Risk (NCT02306551) | Susanne Harder | 2014-09-01 |
| Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? (NCT01964404) | Dartmouth-Hitchcock Medical Center | 2014-07-01 |
| The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia (NCT03667729) | Taipei Medical University | 2014-06-30 |
| Critical Time Intervention-Task Shifting: Randomized Controlled Trial (NCT01995864) | Columbia University | 2014-02-01 |
| The Role of Antidepressants or Antipsychotics in Preventing Psychosis (NCT01724372) | St. Luke's-Roosevelt Hospital Center | 2012-10-01 |
| Mental Health Engagement Network (MHEN) (NCT01473550) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2011-11-01 |
| Yoga and Aerobic Exercise in Psychosis (NCT01207219) | The University of Hong Kong | 2010-11-01 |
| Cannabis and Schizophrenia: Self-Medication and Agonist Treatment (NCT00946348) | Dartmouth-Hitchcock Medical Center | 2009-12-01 |
| Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. (NCT00716755) | Centre for Addiction and Mental Health | 2009-10-01 |
| Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia (NCT01279213) | Universidad Nacional de Rosario | 2009-01-01 |
| Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility Study (NCT00350311) | The University of New South Wales | 2007-02-01 |
| Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder. (NCT00412373) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-12-01 |
| Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. (NCT00397033) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11-01 |
| Study of Amantadine for Weight Stabilization During Olanzapine Treatment (NCT00287352) | University of North Carolina, Chapel Hill | 2005-05-01 |
| Efficacy of Galantamine to Treat Schizophrenia (NCT00232349) | Seattle Institute for Biomedical and Clinical Research | 2005-02-01 |
| Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness (NCT00350493) | The University of New South Wales | 2005-01-01 |
| Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder (NCT00156715) | Dartmouth-Hitchcock Medical Center | 2004-03-01 |
| Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder (NCT00095524) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-03-01 |
| Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) (NCT00579267) | University of South Florida | 2004-02-01 |
| Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness (NCT00199940) | Medical College of Wisconsin | 2003-12-01 |
| Screening for Childhood-Onset Psychotic Disorders (NCT00049738) | National Institute of Mental Health (NIMH) | 2002-10-29 |
| Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual (NCT00498550) | Dartmouth-Hitchcock Medical Center | 2000-10-01 |
| Evaluation of Programs of Coordinated Care and Disease Management (NCT00627029) | Mathematica Policy Research, Inc. | 2000-09-01 |
| Glycine to Treat Psychotic Disorders in Children (NCT00005658) | National Institute of Mental Health (NIMH) | 2000-05-01 |
| Alcoholism and Schizophrenia: Effects of Clozapine (NCT00169026) | Dartmouth-Hitchcock Medical Center | 1999-05-01 |
| Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders (NCT00001656) | National Institute of Mental Health (NIMH) | 1997-06-01 |
| New Drugs in the Treatment of Mood Disorders (NCT00001482) | National Institute of Mental Health (NIMH) | 1995-05-01 |
| A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia (NCT00249119) | Janssen, LP | |